跳到主要内容

科林 布莱克

MD 博士学位

Thoracic medical oncologist
Award-winning clinical researcher

Dr. 科林 布莱克 is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments.

布莱克 received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF.

  • 教育

    University of Pennsylvania Perelman School of Medicine, 2007

  • 派驻

    Hospital of the University of Pennsylvania, Internal Medicine, 2009

  • 奖学金

    UCSF Medical Center, Medical Oncology, 2011

  • 委员会认证

    Internal Medicine, American Board of Internal Medicine

    Medical Oncology, American Board of Internal Medicine

My approach is to learn from every patient and to continually push the envelope in the development of new treatments.

我工作过的诊所

Thoracic Surgery and Oncology Clinic

See both of our San Francisco locations.

我的评论

4.8

总体经验
94年评级
关于我们的流程
2023年11月22日
满意
2023年11月17日
He listened to and asked about how I was doing.
2023年10月25日
Very pleased with him
2023年10月18日
Everyone I dealt with there were top notch professionals. I can't think of anything that could be improved.
2023年9月15日
Dr. 布莱克 and his team are excellent! He is caring informative provides suggestions 等. 等. His follow up is excellent as well! I am so very blessed and thankful to have him as my oncologist!!
2023年8月25日
I would prefer in an in-office appointment. 我从来没见过Dr. 布莱克 face to face or have had the benefit of faving him go over images with me.
2023年7月20日
2023年7月16日
愉快的
2023年6月9日
So grateful Dr 布莱克 is my Dr and part of my medical team.
2023年4月15日
There were no negative points.
2023年4月13日
I felt I was part of my car. Very thorough explanations of my condition. He offered his continued service in the future.
2023年3月16日
Probably one of the best.
2023年2月9日
Dr. 布莱克利太棒了
2023年2月1日
很好
2023年1月14日
The experience is only positive. Clear information on treatment issues without unnecessary information
2022年12月29日
Dr. 布莱克 has been very involved in my care. He always ensure that concerns are addressed immediately.
2022年12月1日
Dr. 布莱克 has always been kind informative and listens to my concerns.
2022年10月27日
Dr. 布莱克 and his team are courteous informed and always helpful.
2022年4月20日
Dr 布莱克 is my oncologist and one of the best physicians I have had in my life. He is extremely knowledgeable caring and takes time with his patients. I am so thankful he has handled my case. 谢谢你!!!
装饰墨丘利的节

Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer

The MTD is the highest dose at which no more than one instance of a dose-limiting toxicity is observed among the 6 participants treated.

招聘

装饰墨丘利的节

Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers

As the primary endpoint for the treatment comparison, it is the duration of time from randomization to the time of disease progression (in the CNS or systemically) or death. In addition, as a secondary endpoint, PFS is measured fr...

招聘

装饰墨丘利的节

Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC 病人

Assessment of Dose-limiting toxicities (DLTs)

招聘

联系我

分享

" class="hidden">邢台123